ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
ADARx Pharmaceuticals's investors include BlackRock, Cormorant Asset Management, Vivo Capital, Lilly Asia Ventures, TCG Crossover.
ADARx Pharmaceuticals is headquartered in San Diego, United States.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
ADARx Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ADARx Pharmaceuticals — Funding & Investors." VCBacked, February 1, 2025, https://www.vcbacked.co/company/adarx-pharmaceuticals. Accessed October 17, 2026.
VCBacked. (2025). ADARx Pharmaceuticals — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/adarx-pharmaceuticals
{{cite web |title=ADARx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/adarx-pharmaceuticals |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated